identified a 10-gene signature based on probable predictive m6a regulatory genes, and these genes (METTL3, WTAP, RBM15, RBM15B, YTHDC2, YTHDF2, HNRNPC, FMR1, LRPPRC, and RBMX) were found to be negatively associated with STAD clinical stage. Here, RBM15 is linked to gastric adenocarcinoma.